Dr. Diane McIntosh Principal Investigator.  Placebo-Controlled Study for  Short-term Treatment of Generalized Anxiety Disorder. Cephalon.  2005-2006.    Principal Investigator.  Placebo-Controlled Study for  Long-term Treatment of Generalized Anxiety Disorder. Cephalon.  2005-2006.   Sub-Investigator.  Placebo-Controlled Study for TRD.  Astra Zeneca. 2006.   Sub-Investigator.  Placebo-Controlled Study for Generalized Anxiety Disorder.  Astra Zeneca. 2006.   Sub-Investigator. Placebo-Controlled Study for Generalized Anxiety Disorder. Sanofi-Aventis. 2006.   Sub-Investigator. Placebo-Controlled Trial for Generalized Anxiety Disorder. Eli Lilly. 2006.   Principal Investigator. Investigator Initiated. Depression Scale. Funding confirmed by Astra Zeneca 2006.   Principal Investigator.  Placebo-Controlled Study Bipolar II Disorder. Submitted for Funding. 2006.   Sub-Investigator. Placebo-Controlled Trial for Dual Diagnosis. Submitted for Funding. 2006.   Dr. Kevin Kjernisted Year Company Drug Investigation 1995-1996 Bayer Ipsapirone Randomized Trial of Ipsapirone versus Placebo in Depression.  (Phase II)  Co-investigator 1996 Wyeth-Ayerst Canada Inc Effexor Open Label Trial of Venlafaxine for Depression. (Hub-Study Phase IV)  Principal Investigator 1996-1997 Solvay Duphar Flesinoxan Placebo Controlled Trial in Elderly Patients with Major Depression.  (Phase lll)  Principal Investigator 1996-1997 Pfizer Zoloft Placebo controlled trial in Social Phobia.  (Phase III) Co-investigator 1996-1997 Pfizer Zoloft / CBT Placebo controlled trial in Panic Disorder.  (Phase III) Principal Investigator 1998 Eli Lilly Zyprexa Open Label Trial of Olanzapine for Schizophrenia. (Phase IV)   Principal Investigator 1998 Bristol Myers Squibb Serzone Open Label Trial with Nefazodone for Hypochondriasis. (Phase IV) Principal Investigator 1998-1999 SmithKline Beecham Paxil Placebo controlled Trial in Social Phobia.  (Phase III) Principal Investigator 1998-1999 SmithKline Beecham Paxil Placebo controlled Trial in Post Traumatic Stress Disorder.  (Phase lll)  Principal Investigator 1998-1999 Novartis NKP608A Placebo Controlled Trial in Social Phobia. (Phase ll) Principal Investigator 2000 Wyeth-Ayerst Effexor XR Placebo Controlled Trial in Social Phobia. (Phase lll) Principal Investigator 2000 Lundbeck LU26-054 Placebo Controlled Trial in Social Phobia.  (Phase ll) Principal Investigator 2000 SmithKline Beecham Paxil Placebo Controlled Trial in PMDD.  (Phase lll) Principal Investigator 2000 SmithKline Beecham Paxil Placebo Controlled Trial in Child and Adolescent Generalized Social Anxiety Disorder.  (Phase lll) Principal Investigator 2000 Organon Remeron/Zoloft Comparative Efficacy and Tolerability in Major Depression.  (Phase IV) Principal Investigator 2000 Pfizer Zoloft Placebo Controlled trial in Child and Adolescent Major Depression.  (Phase lll)  Co-Investigator 2000 Wyeth-Ayerst Effexor XR Placebo Controlled Trial in Panic Disorder. (Phase III) Principal Investigator 2001 Wyeth-Ayerst Effexor XR Placebo Controlled Trial in Child and Adolescent Panic Disorder. (Phase III)  Principal Investigator 2001 Sanofi SL 65.1498-00 Placebo Controlled Comparative Trial of SL 65.1498-00 vs. Lorazepam in Generalized Anxiety Disorder.  (Phase II)  Principal Investigator 2001 Wyeth-Ayerst Effexor XR Long-term Placebo Controlled Trial for Panic Disorder. (Phase III) Principal Investigator 2001 SmithKline Beecham Paxil CR Longterm Extension Paroxetine CR Trial for PMDD. (Phase III)  Principal Investigator 2002 GlaxoSmithKline GW 597599B Eight week Randomized Placebo Trial for Major Depression.  (Phase II)   Principal Investigator 2002 GlaxoSmithKline Paxil CR Placebo Controlled Intermittent Dosing Trial for PMDD. (Phase III) Principal Investigator 2003 H.Lundbeck A/S Escitalopram Placebo Controlled Comparative Trial for OCD. (Phase III). Principal Investigator 2004 AstraZeneca Seroquel Adjunct to Mood Stabilizers in Maintenance Treatment of Bipolar I Disorder. (Phase III)   Principal Investigator 2004 Eli Lilly Duloxetine Open-Label Trial for Melancholic Depression.  (Phase IV) Principal Investigator 2004 Eli Lilly Duloxetine Open-Label Compassionate Use for Completers of Previous Duloxetine Clinical Trial. Principal Investigator 2005 Eli Lilly Duloxetine Placebo Controlled Comparative Trial for GAD. (Phase III). Principal Investigator 2005 Cephalon Gabitril Placebo Controlled, Flexible Dose Trial for GAD. (Phase III). Principal Investigator 2005 Cephalon Gabitril Open Label, Flexible Dose Trial for GAD.  (Phase III) Principal Investigator « Back to Research © Copeman Neuroscience Centre 2007 Privacy Policy | Site Map | Website Design